je.st
news
Tag: hepatitis
Will hepatitis C drug continue blockbuster sales?
2014-07-24 00:20:32| Biotech - Topix.net
Gilead Sciences' $1,000-a-day hepatitis C pill is facing a firestorm of criticism from insurers and lawmakers, but none of those obstacles are likely to stop the Foster City company from reporting blockbuster revenues during the second quarter today.
Tags: sales
continue
drug
hepatitis
Gilead Drug Combination Cures Hepatitis C in HIV Patients
2014-07-20 17:42:57| Biotech - Topix.net
Gilead Sciences Inc.'s Solvadi, controversial because of its price, helps cure hepatitis C in people with HIV, according to researchers who say the drug has the potential to limit a top cause of death in these patients.
Tags: combination
drug
patients
hiv
UPDATE 2-J&J beats forecasts, helped by new hepatitis C drug
2014-07-15 19:05:54| Food - Topix.net
Johnson & Johnson reported higher-than-expected quarterly revenue and earnings, benefiting from strong sales of its Olysio treatment for hepatitis C. Olysio, which U.S. regulators approved in November, chalked up sales of $831 million for the second quarter and $1.19 billion for the year to date.
Tags: update
drug
helped
beats
U.S. senators ask Gilead to explain cost of Sovaldi hepatitis drug
2014-07-11 18:47:55| Biotech - Topix.net
Two members of the U.S. Senate Finance Committee, including Chairman Ron Wyden, on Friday asked Gilead Sciences Inc to defend the more than $80,000 cost of its breakthrough treatment for hepatitis C, citing the expense to federal healthcare programs.
Tags: cost
drug
explain
senators
Appendix D - Hepatitis B Vaccine Declination
2014-07-01 18:35:39| PortlandOnline
City Risk Bloodborne Pathogen Program Guideline Appendix D - Hepatitis B Vaccine Declination PDF Document, 84kbCategory: Appendices - BBP Guideline & Exposure Control Plan
Tags: appendix
hepatitis
vaccine
declination
Sites : [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] next »